microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/ β-catenin signaling pathway

ConclusionsCollectively, all the above findings revealed that miR-377-3p exerted anti-OS functions viaCUL1 and EMT and Wnt/β-catenin pathways. These results may contribute to the development of clinical OS treatment.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research